Amgen (AMGN) returns
Amgen returns over 10 years
$1,000 invested in Amgen ten years ago was worth $4,323 at the close on October 30, 2026, with dividends reinvested: an average return of 15.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +10.6% | — | $1,106 | -0.9% |
| 3 months | +20.9% | — | $1,209 | +2.1% |
| Year to date | +45.3% | — | $1,453 | +11.7% |
| 1 year | +64.0% | — | $1,640 | +12.4% |
| 3 years | +93.7% | +24.7% | $1,937 | +88.5% |
| 5 years | +163.1% | +21.3% | $2,631 | +76.0% |
| 10 years | +332.3% | +15.8% | $4,323 | +316.6% |
Amgen return by calendar year
| Year | AMGN | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +45.3% | +11.7% | +33.6% |
| 2025 | +29.7% | +17.7% | +11.9% |
| 2024 | -6.8% | +24.9% | -31.6% |
| 2023 | +13.5% | +26.2% | -12.7% |
| 2022 | +20.4% | -18.2% | +38.6% |
| 2021 | +0.9% | +28.7% | -27.9% |
| 2020 | -2.0% | +18.4% | -20.4% |
| 2019 | +27.6% | +31.2% | -3.6% |
| 2018 | +15.2% | -4.6% | +19.7% |
| 2017 | +22.2% | +21.7% | +0.5% |
| 2016 | -7.5% | +12.0% | -19.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: AMGN financials · AMGN valuation
No forecast, no recommendation. This page describes Amgen from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.